Furthermore, recognition of different components of PDC in AMA-positive PBC patients may define possible clinical association with liver and cardiac disease, and AMA may be detected in rheumatic disease patients without PBC and liver function alterations even years before the clinical manifestations of the liver disease. Here, PDC is linked to rheumatic disorder.